# A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh

> **NCT04434144** · — · COMPLETED · sponsor: **Upazila Health & Family Planning Officer's (UHFPO) Office, Chakoria, Cox's Bazar** · enrollment: 116 (actual)

## Conditions studied

- Ivermectin
- Hydroxychloroquine
- COVID19

## Interventions

- **DRUG:** Ivermectin + Doxycycline
- **DRUG:** Hydroxychloroquine + Azithromycin

## Key facts

- **NCT ID:** NCT04434144
- **Lead sponsor:** Upazila Health & Family Planning Officer's (UHFPO) Office, Chakoria, Cox's Bazar
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-02
- **Primary completion:** 2020-06-05
- **Final completion:** 2020-06-05
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2020-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04434144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04434144, "A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04434144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*